Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy

Japanese Circulation Journal

Volumn 65, Issue 9, 2001, Pages 797-802

  Kanzaki, Y ^a   Terasaki, F ^a   Okabe, M ^a   Hayashi, T ^a   Toko, H ^a   Shimomura, H ^a   Fujioka, S ^a   Kitaura, Y ^a   Kawamura, K ^a   Horii, Y ^a   Isomura, T ^a   Suma, H ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Dilated cardiomyopathy; Myocardial inflammation; Partial left ventriculectomy; Pathology

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; FEMALE; HEART DILATATION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART SIZE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MORTALITY; MYOCARDITIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, DILATED; CHEMOTAXIS; DNA, VIRAL; ENTEROVIRUS; FEMALE; HEART VENTRICLES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MACROPHAGES; MALE; MIDDLE AGED; MYOCARDITIS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0346159264     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.797     Document Type: Article

References (38)

1. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
2. Partial left ventriculectomy to treat end-stage heart disease
3. Early results with partial left ventriculectomy
4. Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation: Short-term results
5. Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance
6. Nontransplant cardiac surgery for end-stage cardiomyopathy
7. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
8. Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: Correlation with interstitial fibrosis and foci of activated T lymphocytes
9. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy
10. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
11. Immunohistochemical evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy
12. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction
13. Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction
14. Genomic detection of enteroviruses in the myocardium: Studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy
15. Molecular detection and differentiation of enteroviruses in endomyocardial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis
16. Idiopathic dilated cardiomyopathy: Analysis of 152 necropsy patients
17. Histopathological types of cardiac fibrosis in myocardial disease
18. Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy: Light microscopic, immunohistochemical and virological analyses of myocardium specimens obtained by partial left ventriculectomy
19. The presence of inflammation in cases of dilated cardiomyopathy: Immunohistochemical and virological analyses of myocardium specimens obtained by partial left ventriculectomy
20. Histopathology of endomyocardial biopsies from patients with idiopathic cardiomyopathy; quantitative evaluation based on multivariate statistical analysis
21. Point counting methods
22. Analysis of enterovirus genotypes using single-strand conformation polymorphisms of polymerase chain reaction products
23. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy
24. Determinants of midterm outcome of partial left ventriculectomy in dilated cardiomyopathy
25. Phenotypic patterns of mononuclear cells in dilated cardiomyopathy
26. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy
27. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future
28. The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID)
29. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy
30. Treatment of chronic myocarditis with corticosteroids
31. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
32. A clinical trial of immunosuppressive therapy for myocarditis
33. A morphological analysis of chronic myocarditis
34. Clinical and pathologic features of chronic myocarditis: Four autopsy cases presenting as dilated cardiomyopathy in life
35. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure
36. Viral infection and the pathogenesis of dilated cardiomyopathy
37. Mechanisms of immune-mediated myocyte injury